Angiopoietins as promising biomarkers and potential therapeutic targets in brain injury

Pathophysiology

Volumn 20, Issue 1, 2013, Pages 15-21

  Chittiboina, Prashant ^a   Ganta, Vijay ^b   Monceaux, Christopher P ^b   Scott, L Keith ^b   Nanda, Anil ^a   Alexander, J Steven ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b NONE   (United States)

Author keywords

Angiopoietin; Biomarker; Brain injury; Subarachnoid hemorrhage; Traumatic brain injury

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; BIOLOGICAL MARKER; OSTEOPONTIN; VASCULOTROPIN;

ANEURYSM RUPTURE; ANGIOGENESIS; APACHE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL INJURY; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN VASOSPASM; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GLIOBLASTOMA; HEMATOPOIETIC STEM CELL; HUMAN; HYDROCEPHALUS; INFLAMMATION; INJURY SCALE; LEUKEMIA CELL; MESENCHYME CELL; MICROVASCULATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MUSCLE CELL; NERVOUS SYSTEM INJURY; NEUROENDOCRINE TUMOR; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN TARGETING; SUBARACHNOID HEMORRHAGE; TISSUE INJURY; TRAUMATIC BRAIN INJURY;

EID: 84878191794     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2012.02.004     Document Type: Article

References (49)

1. Sacco R.L., Wolf P.A., Bharucha N.E., et al. Subarachnoid and intracerebral hemorrhage: natural history, prognosis, and precursive factors in the Framingham Study. Neurology 1984, 34(7):847-854.
2. Ingall T.J., Whisnant J.P., Wiebers D.O., O'Fallon W.M. Has there been a decline in subarachnoid hemorrhage mortality?. Stroke 1989, 20(6):718-724.
3. G.I. Jallo, Subarachnoid Hemorrhage: eMedicine Neurology, 2010. Available from: (accessed 27.09.10). http://emedicine.medscape.com/article/1164341-overview.
4. Thurman D.J., Alverson C., Dunn K.A., Guerrero J., Sniezek J.E. Traumatic brain injury in the United States: a public health perspective. J. Head Trauma Rehabil. 1999, 14(6):602-615.
5. Lu J., Marmarou A., Choi S., et al. Mortality from traumatic brain injury. Acta Neurochir. Suppl. 2005, 95:281-285.
6. Carney N.A., Ghajar J. Guidelines for the management of severe traumatic brain injury. Introduction. J. Neurotrauma 2007, 24(Suppl. 1):S1-S2.
7. Hegen A., Koidl S., Weindel K., et al. Expression of angiopoietin-2 in endothelial cells is controlled by positive and negative regulatory promoter elements. Arterioscler. Thromb. Vasc. Biol. 2004, 24(10):1803-1809.
8. Morisada T., Kubota Y., Urano T., Suda T., Oike Y. Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium 2006, 13(2):71-79.
9. Oike Y., Yasunaga K., Suda T. Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis. Int. J. Hematol. 2004, 80(1):21-28.
10. Valenzuela D.M., Griffiths J.A., Rojas J., et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(5):1904-1909.
11. Kukk E., Wartiovaara U., Gunji Y., et al. Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells. Brit. J. Haematol. 1997, 98(1):195-203.
12. Partanen J., Armstrong E., Mäkelä T.P., et al. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol. Cell. Biol. 1992, 12(4):1698-1707.
13. Marron M.B., Singh H., Tahir T.A., et al. Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J. Biol. Chem. 2007, 282(42):30509-30517.
14. Chan B., Yuan H.-T., Ananth Karumanchi S., Sukhatme V.P. Receptor tyrosine kinase Tie-1 overexpression in endothelial cells upregulates adhesion molecules. Biochem. Biophys. Res. Commun. 2008, 371(3):475-479.
15. Hori S., Ohtsuki S., Hosoya K.-i., Nakashima E., Terasaki T. A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J. Neurochem. 2004, 89(2):503-513.
16. Fiedler U., Scharpfenecker M., Koidl S., et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004, 103(11):4150-4156.
17. Fiedler U., Reiss Y., Scharpfenecker M., et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat. Med. 2006, 12(2):235-239.
18. Udani V., Santarelli J., Yung Y., et al. Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors. Neurol. Res. 2005, 27(8):801-806.
19. Lee S.-W., Kim W.J., Choi Y.K., et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat. Med. 2003, 9(7):900-906.
20. H. Yu, P. Wang, P. An, X. Yixue, Recombinant human Angiopoietin-1 ameliorates the expressions of ZO-1, occludin, VE-cadherin, and PKCα signaling after focal cerebral ischemia/reperfusion in rats, J. Mol. Neurosci. (2011). Available from: (accessed 27.10.11). http://www.ncbi.nlm.nih.gov/pubmed/21710361.
21. Fischer M., Broessner G., Dietmann A., et al. Angiopoietin-1 is associated with cerebral vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage. BMC Neurol. 2011, 11:59.
22. Nag S., Manias J.L., Stewart D.J. Pathology and new players in the pathogenesis of brain edema. Acta Neuropathol. 2009, 118(2):197-217.
23. Liu X.S., Chopp M., Zhang R.L., et al. Angiopoietin 2 mediates the differentiation and migration of neural progenitor cells in the subventricular zone after stroke. J. Biol. Chem. 2009, 284(34):22680-22689.
24. Lee H.S., Han J., Bai H.-J., Kim K.-W. Brain angiogenesis in developmental and pathological processes: regulation, molecular and cellular communication at the neurovascular interface. FEBS J. 2009, 276(17):4622-4635.
25. Lobov I.B., Brooks P.C., Lang R.A. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(17):11205-11210.
26. Ahmed A., Fujisawa T. Multiple roles of angiopoietins in atherogenesis. Curr. Opin. Lipidol. 2011, 22(5):380-385.
27. Zacharek A., Chen J., Zhang C., et al. Nitric oxide regulates Angiopoietin1/Tie2 expression after stroke. Neurosci. Lett. 2006, 404(1-2):28-32.
28. Zhou H., Tang T., Guo C., et al. Expression of Angiopoietin-1 and the receptor Tie-2 mRNA in rat brains following intracerebral hemorrhage. Acta Neurobiol. Exp. (Wars.) 2008, 68(2):147-154.
29. Suzuki H., Hasegawa Y., Kanamaru K., Zhang J.H. Mechanisms of osteopontin-induced stabilization of blood-brain barrier disruption after subarachnoid hemorrhage in rats. Stroke 2010, 41(8):1783-1790.
30. Lukasz A., Hellpap J., Horn R., et al. Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays. Crit. Care 2008, 12(4):R94.
31. Sie M., Wagemakers M., Molema G., et al. The angiopoietin 1/angiopoietin 2 balance as a prognostic marker in primary glioblastoma multiforme. J. Neurosurg. 2009, 110(1):147-155.
32. Sobrino T., Arias S., Rodríguez-González R., et al. High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 2009, 29(12):1968-1974.
33. Srirajaskanthan R., Dancey G., Hackshaw A., et al. Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis. Endocr. Relat. Cancer 2009, 16(3):967-976.
34. Ganter M.T., Cohen M.J., Brohi K., et al. Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?. Ann. Surg. 2008, 247(2):320-326.
35. Gallagher D.C., Parikh S.M., Balonov K., et al. Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 2008, 29(6):656-661.
36. Nag S., Papneja T., Venugopalan R., Stewart D.J. Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown. Lab. Invest. 2005, 85(10):1189-1198.
37. Marmarou A. A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg. Focus 2007, 22(5):E1.
38. Voldby B. Pathophysiology of subarachnoid haemorrhage. Experimental and clinical data. Acta Neurochir. Suppl. (Wien.) 1988, 45:1-6.
39. De Salles A.A., Muizelaar J.P., Young H.F. Hyperglycemia, cerebrospinal fluid lactic acidosis, and cerebral blood flow in severely head-injured patients. Neurosurgery 1987, 21(1):45-50.
40. Nourhaghighi N., Teichert-Kuliszewska K., Davis J., Stewart D.J., Nag S. Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab. Invest. 2003, 83(8):1211-1222.
41. Beck H., Acker T., Wiessner C., Allegrini P.R., Plate K.H. Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat. Am. J. Pathol. 2000, 157(5):1473-1483.
42. Fremont R.D., Koyama T., Calfee C.S., et al. Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. J. Trauma 2010, 68(5):1121-1127.
43. Ganta V.C., Chittiboina P., Mccarthy P., et al. Abstracts of the 61st meeting of the british microcirculation society. Microcirculation 2011, 18(5):415.
44. Kurosaka D., Hirai K., Nishioka M., et al. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. J. Rheumatol. 2010, 37(6):1121-1128.
45. Chen J., Yu H., Sun K., et al. Promoter variant of angiopoietin-2 and plasma angiopoietin-2 are associated with risk of stroke recurrence in lacunar infarct patients. Biochem. Biophys. Res. Commun. 2010, 398(2):212-216.
46. Lovegrove F.E., Tangpukdee N., Opoka R.O., et al. Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS ONE 2009, 4(3):e4912.
47. Ganta V.C., Cromer W., Mills G.L., et al. Angiopoietin-2 in experimental colitis. Inflamm. Bowel Dis. 2010, 16(6):1029-1039.
48. van der Heijden M., van Nieuw Amerongen G.P., Chedamni S., van Hinsbergh V.W.M., Johan Groeneveld A.B. The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury. Expert Opin. Ther. Targets 2009, 13(1):39-53.
49. Nomura S., Shouzu A., Omoto S., et al. Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes. J. Atheroscler. Thromb. 2009, 16(2):83-90.